Mohamed Rizk

机构：University of Michigan · ORCID：0000-0002-1059-1524

发表论文 12 篇 · 总被引 69 次 · h-index 5

代表论文

• KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis (2019 · Blood Advances · 被引 25)
• Akt inhibition synergizes with polycomb repressive complex 2 inhibition in the treatment of multiple myeloma (2019 · Cancer Science · 被引 24)
• Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia (2024 · Leukemia · 被引 6)
• UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease (2023 · Leukemia · 被引 5)
• The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells (2021 · Scientific Reports · 被引 5)
• The Preclinical Activities of PTC596, a Novel Tubulin Binding Agent That Down-Regulates BMI1, Alone and in Combination with Bortezomib in Multiple Myeloma (2019 · Blood · 被引 2)